Company Info
Phone(818) 661-5000
Year Established
1991
Ticker
MNKD
Exchange
NASDAQ
Contacts
Michael CastagnaCEO
Christopher Prentiss
CFO
Burkhard Blank, MD
CMO
Lauren Sabella
COO
David Thomson, PhD, JD
General Counsel
Company Description
MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases.